Henry Ofori

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 09, 2022
Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2- Early Breast Cancer.

Farah Raheem, Henry Ofori, Lacey Simpson

Pageof 1

Frequent Collaborators

1 joint publications

Lacey Simpson

1 joint publications

Vishal Shah